INTERCEPT PHARMACEUTICALS, INC. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Intercept Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2022.
  • Intercept Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was -$254K, a 20.1% increase year-over-year.
  • Intercept Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$267M, a 24010% decline from 2021.
  • Intercept Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $1.12M.
  • Intercept Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was -$693K, a 100% decline from 2019.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$267M -$268M -24010% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-02
2021 $1.12M +$1.81M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-02
2020 -$693K -$458M -100% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-02
2019 $458M +$194M +73.6% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-02
2018 $264M +$261M +9186% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $2.84M -$412M -99.3% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-25
2016 $414M -$151M -26.7% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 $565M +$374M +196% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-28
2014 $191M +$125M +189% Jan 1, 2014 Dec 31, 2014 10-K 2015-03-02
2013 $66.1M -$42.3M -39.1% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-02
2012 $108M +$109M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-02
2011 -$250K -$24.9M -101% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-14
2010 $24.6M Jan 1, 2010 Dec 31, 2010 10-K 2013-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.